CAGNA, MARTA
CAGNA, MARTA
DIPARTIMENTO DI MEDICINA INTERNA E TERAPIA MEDICA
Changes in glutathione content in liver diseases: An update
2021-01-01 Vairetti, M.; Di Pasqua, L. G.; Cagna, M.; Richelmi, P.; Ferrigno, A.; Berardo, C.
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
2022-01-01 Di Pasqua, Laura Giuseppina; Cagna, Marta; Berardo, Clarissa; Vairetti, Mariapia; Ferrigno, Andrea
From non alcoholic steatohepatitis to end stage liver disease: the molecular mechanisms involved in liver fibrosis and regeneration
2023-12-18 Cagna, Marta
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH
2024-01-01 Di Pasqua, L. G.; Cagna, M.; Palladini, G.; Croce, A. C.; Cadamuro, M.; Fabris, L.; Perlini, S.; Adorini, L.; Ferrigno, A.; Vairetti, M.
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet
2021-01-01 Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Mannucci, B.; Milanesi, G.; Croce, A. C.; Ferrigno, A.; Vairetti, M.
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis
2022-01-01 Palladini, G.; Di Pasqua, L. G.; Cagna, M.; Croce, A. C.; Perlini, S.; Mannucci, B.; Profumo, A.; Ferrigno, A.; Vairetti, M.
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death
2021-01-01 Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Verta, R.; Collotta, D.; Nicoletti, F.; Ferrigno, A.; Collino, M.; Vairetti, M.
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats
2021-01-01 Filibian, M.; Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Vairetti, M.; Ferrigno, A.
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats
2023-01-01 Di Pasqua, L. G.; Bosco, O.; Cagna, M.; Sun, P.; Kauschke, S. G.; Vairetti, M.; Croce, A. C.; Ferrigno, A.
MPEP administration reduces steatosis and inflammation in ob/ob mice
2022-01-01 DI PASQUA, LAURA GIUSEPPINA; Cagna, Marta; Berardo, CLARISSA ANGELA IRIS; Cleta Croce, Anna; Nicoletti, Ferdinando; Vairetti, Mariapia; Ferrigno, Andrea
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice
2023-01-01 Ferrigno, A.; Cagna, M.; Bosco, O.; Trucchi, M.; Berardo, C.; Nicoletti, F.; Vairetti, M.; Di Pasqua, L. G.
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research
2020-01-01 Berardo, C.; Di Pasqua, L. G.; Cagna, M.; Richelmi, P.; Vairetti, M.; Ferrigno, A.
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH
2022-01-01 Cagna, Marta; Palladini, Giuseppina; DI PASQUA, LAURA GIUSEPPINA; Cleta Croce, Anna; Adorini, Luciano; Ferrigno, Andrea; Vairetti, Mariapia
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats
2022-01-01 Palladini, G.; Cagna, M.; Di Pasqua, L. G.; Adorini, L.; Croce, A. C.; Perlini, S.; Ferrigno, A.; Berardo, C.; Vairetti, M.
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH
2023-01-01 Cagna, M.; Palladini, G.; Croce, A. C.; Adorini, L.; Ferrigno, A.; Vairetti, M.; Di Pasqua, L. G.
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH
2022-01-01 Cagna, M.; Di Pasqua, L. G.; Berardo, C.; Palladini, G.; Adorini, L.; Ferrigno, A.; Vairetti, M.
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats
2021-01-01 Di Pasqua, L. G.; Berardo, C.; Palladini, G.; Cagna, M.; Adorini, L.; Richelmi, P.; Ferrigno, A.; Vairetti, M.
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion
2020-01-01 Di Pasqua, L. G.; Palladini, G.; Berardo, C.; Siciliano, V.; Cagna, M.; Adorini, L.; Richelmi, P.; Ferrigno, A.; Vairetti, M.
SerpinB3 administration protects liver against ischemia-reperfusion injury
2022-01-01 Turato, C.; Vairetti, M.; Cagna, M.; Biasiolo, A.; Ferrigno, A.; Quarta, S.; Ruvoletto, M.; De Siervi, S.; Pontisso, P.; Di Pasqua, L. G.
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury
2020-01-01 Di Pasqua, Laura Giuseppina; Palladini, Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Cagna, Marta; Adorini, Luciano; Richelmi, Plinio; Ferrigno, Andrea; Vairetti, Mariapia
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Changes in glutathione content in liver diseases: An update | 1-gen-2021 | Vairetti, M.; Di Pasqua, L. G.; Cagna, M.; Richelmi, P.; Ferrigno, A.; Berardo, C. | |
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update | 1-gen-2022 | Di Pasqua, Laura Giuseppina; Cagna, Marta; Berardo, Clarissa; Vairetti, Mariapia; Ferrigno, Andrea | |
From non alcoholic steatohepatitis to end stage liver disease: the molecular mechanisms involved in liver fibrosis and regeneration | 18-dic-2023 | Cagna, Marta | |
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH | 1-gen-2024 | Di Pasqua, L. G.; Cagna, M.; Palladini, G.; Croce, A. C.; Cadamuro, M.; Fabris, L.; Perlini, S.; Adorini, L.; Ferrigno, A.; Vairetti, M. | |
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet | 1-gen-2021 | Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Mannucci, B.; Milanesi, G.; Croce, A. C.; Ferrigno, A.; Vairetti, M. | |
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis | 1-gen-2022 | Palladini, G.; Di Pasqua, L. G.; Cagna, M.; Croce, A. C.; Perlini, S.; Mannucci, B.; Profumo, A.; Ferrigno, A.; Vairetti, M. | |
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death | 1-gen-2021 | Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Verta, R.; Collotta, D.; Nicoletti, F.; Ferrigno, A.; Collino, M.; Vairetti, M. | |
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats | 1-gen-2021 | Filibian, M.; Di Pasqua, L. G.; Berardo, C.; Cagna, M.; Vairetti, M.; Ferrigno, A. | |
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats | 1-gen-2023 | Di Pasqua, L. G.; Bosco, O.; Cagna, M.; Sun, P.; Kauschke, S. G.; Vairetti, M.; Croce, A. C.; Ferrigno, A. | |
MPEP administration reduces steatosis and inflammation in ob/ob mice | 1-gen-2022 | DI PASQUA, LAURA GIUSEPPINA; Cagna, Marta; Berardo, CLARISSA ANGELA IRIS; Cleta Croce, Anna; Nicoletti, Ferdinando; Vairetti, Mariapia; Ferrigno, Andrea | |
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice | 1-gen-2023 | Ferrigno, A.; Cagna, M.; Bosco, O.; Trucchi, M.; Berardo, C.; Nicoletti, F.; Vairetti, M.; Di Pasqua, L. G. | |
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research | 1-gen-2020 | Berardo, C.; Di Pasqua, L. G.; Cagna, M.; Richelmi, P.; Vairetti, M.; Ferrigno, A. | |
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH | 1-gen-2022 | Cagna, Marta; Palladini, Giuseppina; DI PASQUA, LAURA GIUSEPPINA; Cleta Croce, Anna; Adorini, Luciano; Ferrigno, Andrea; Vairetti, Mariapia | |
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats | 1-gen-2022 | Palladini, G.; Cagna, M.; Di Pasqua, L. G.; Adorini, L.; Croce, A. C.; Perlini, S.; Ferrigno, A.; Berardo, C.; Vairetti, M. | |
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH | 1-gen-2023 | Cagna, M.; Palladini, G.; Croce, A. C.; Adorini, L.; Ferrigno, A.; Vairetti, M.; Di Pasqua, L. G. | |
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH | 1-gen-2022 | Cagna, M.; Di Pasqua, L. G.; Berardo, C.; Palladini, G.; Adorini, L.; Ferrigno, A.; Vairetti, M. | |
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats | 1-gen-2021 | Di Pasqua, L. G.; Berardo, C.; Palladini, G.; Cagna, M.; Adorini, L.; Richelmi, P.; Ferrigno, A.; Vairetti, M. | |
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion | 1-gen-2020 | Di Pasqua, L. G.; Palladini, G.; Berardo, C.; Siciliano, V.; Cagna, M.; Adorini, L.; Richelmi, P.; Ferrigno, A.; Vairetti, M. | |
SerpinB3 administration protects liver against ischemia-reperfusion injury | 1-gen-2022 | Turato, C.; Vairetti, M.; Cagna, M.; Biasiolo, A.; Ferrigno, A.; Quarta, S.; Ruvoletto, M.; De Siervi, S.; Pontisso, P.; Di Pasqua, L. G. | |
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury | 1-gen-2020 | Di Pasqua, Laura Giuseppina; Palladini, Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Cagna, Marta; Adorini, Luciano; Richelmi, Plinio; Ferrigno, Andrea; Vairetti, Mariapia |